Forest Expects Lexapro Scripts To Grow 2%-3% Through Lilly Cymbalta Launch
Lexapro's safety profile will be a distinguishing feature as Lilly launches its SNRI, Forest says. In its first full year of sales, Lexapro tops the $1 bil. mark.
Lexapro's safety profile will be a distinguishing feature as Lilly launches its SNRI, Forest says. In its first full year of sales, Lexapro tops the $1 bil. mark.